ArticleScientific reports2025
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenetics, Oxidative Stress, and the Microbiome in Endometriosis: Toward an Integrated Mechanistic Framework for Precision Medicine.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study explores the relationship between inflammatory biomarkers and the risk of endometriosis, aiming to develop a predictive model using National Health and Nutrition Examination Survey (1999-2006) data. The dataset included 4,089 females with complete hematological inflammatory indicators and covariates. A machine-learning model was developed using Shapley Additive exPlanations (SHAP), incorporating variables such as age, race, monocyte percentage (MONO%), platelet count (PLT), body mass index (BMI), platelet-to-albumin ratio (PAR), neutrophil percentage-to-albumin ratio (NPAR), lymphocyte-to-monocyte ratio (LMR), and educational attainment. The Gradient Boosting (XGBoost) model outperformed the other models, demonstrating excellent classification ability. SHAP analysis identified age, race, MONO%, PLT, BMI, PAR, NPAR, LMR, and educational attainment as the most influential predictors. The model was refined into an interactive web-based tool for real-time risk predictions. These findings highlight the potential of combining demographic data with inflammatory biomarkers to improve early diagnosis of endometriosis, emphasizing their significance in risk modeling. The use of non-invasive and cost-effective routine blood tests may help reduce delays in early diagnosis. Although the XGBoost model demonstrated strong performance, further validation in larger and more diverse populations is warranted to confirm its generalizability and clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.